An association between type 1 diabetes and the interleukin-1 receptor type 1 gene

Human Immunology

Volumn 51, Issue 1, 1996, Pages 41-48

  Metcalfe, Karl A ^a   Hitman, Graham A ^a   Pociot, Flemming ^b   Bergholdt, Regine ^b   Tuomilehto Wolf, Eva ^c   Tuomilehto, Jaakko ^c   Viswanathan, Moopil ^d   Ramachandran, Ambady ^d   Nerup, Jørn ^b  

^a ROYAL LONDON HOSPITAL   (United Kingdom)

^b STENO DIABETES CENTER   (Denmark)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d Diabetes Research Centre Tamil Nadu   (India)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DR3 ANTIGEN; HLA DR4 ANTIGEN; INTERLEUKIN 1 RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PANCREAS ISLET CELL ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHROMOSOME 2Q; CONTROLLED STUDY; FEMALE; GENE LOCUS; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; GENOTYPE; HIGH RISK POPULATION; HLA TYPING; HUMAN; IMMUNOGENETICS; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADOLESCENT; ALLELES; CHILD; DIABETES MELLITUS, TYPE 1; DISEASE SUSCEPTIBILITY; FEMALE; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; MALE; RECEPTORS, INTERLEUKIN-1;

EID: 0030297731     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(96)00206-6     Document Type: Article

References (42)

1. 1. Davies JL, Kawaguchi Y, Bennett ST, Copeman JB, Cordell HJ, Pritchard LE, Reed PW, Gough SCL, Jenkins SC, Palmer SM, Balfour KM, Rowe BR, Farrall M, Barnett AH, Bain SC, Todd JA: A genome-wide search for human type 1 diabetes susceptibility genes. Nature 371: 130, 1994.
2. 2. Hashimoto L, Habita C, Beressi JP, Delepine M, Besse C, Cambon-Thomsen A, Deschamps I, Rotter JI, Djoulah S, James MR, Froguel P, Weissenbach J, Lathrop GM, Julier C: Genetic mapping of a susceptibility locus for insulin-dependent mellitus on chromosome 11q. Nature 371: 161, 1994.
3. 3. Field LL, Tobias R, Magnus T: A locus on chromosome 15q26 (IDDM 3) produces susceptibility to insulin dependent diabetes mellitus. Nat Genet 8:189, 1994.
4. 4. Copeman JB, Cucca F, Hearne CM, Cornall RJ, Reed PW, Rønningen KS, Undlien DE, Nistico L, Buzetti R, Tosi R, Pociot F, Nerup J, Cornelis F, Barnett AH, Bain SC, Todd JA: Linkage disequilibrium mapping of a type 1 diabetes susceptibility gene (IDDM 7) to chromosome 2q31-q33. Nat Genet 9:80, 1995.
5. 5. Owerbach D, Gabbay KH: The HOXD8 locus is linked to type 1 diabetes. Interaction with chromosome 6 and 11 disease susceptibility genes. Diabetes 44:132, 1995.
6. 6. Webb AC, Collins KL, Auron PE, Eddy RL, Nakai H, Byers MG, Haley LL, Henry WM, Shows TB: Interleukin-1 gene (IL-1) assigned to long arm of human chromosome 2. Lymphokin Res 5:77, 1986.
7. 7. Lafage M, Maroc N, Dubreuil P, Malefijit RDW, Pebusquue M-J, Carcassonne Y, Mannoni P: The human interleukin-1α gene is located on the long arm of chromosome 2 at band q13-Blood 73:104, 1989.
8. 8. Copeland NG, Silan CM, Kingsley DM, Jenkins NA, Cannizzaro LA, Croce CM, Heubner K, Sims JE: Chromosomal localisation of murine and human IL-1 receptor genes. Genomics 9:44, 1991.
9. 9. Lennard A, Gorman P, Carrier M, Griffiths S, Scotney H, Sheer D, Solari R: Cloning and chromosome mapping of the interleukin-1 receptor antagonist gene. Cytokine 4: 83, 1992.
10. 10. Steinkasserer A, Spur NK, Cox S, Jeggo P, Sim RB: The human IL-1 receptor antagonist gene (IL1RN) maps to chromosome 2q14-q21, in the region of the IL-1α and IL-1β loci. Genomics 13:654, 1992.
11. 11. Dinarello CA: Interleukin-1 and interleukin-1 antagonism. Blood 77:1627, 1991.
12. 12. Mandrup-Poulsen T, Zumsteg U, Reimers J, Pociot F, Morch L, Helqvist S, Dinarello CA, Nerup J: Involvement of interleukin 1 and interleukin 1 antagonist in pancreatic β-cell destruction in insulin-dependent diabetes mellitus. Cytokine 5:185, 1993.
13. 13. Zumsteg U, Reimers JI, Pociot F, Motch L, Helqvist S, Brendel M, Alejandro R, Mandrup-Poulsen T, Dinarello CA, Nerup J: Differential interleukin-1 receptor antagonism on pancreatic beta and alpha cells. Studies in rodent and human islets and in normal rats. Diabetologia 36: 759, 1993.
14. 14. Sims JE, Gayle MA, Slack JL, Alderson MR, Bird TA, Giri JG, Colotta F, Re F, Mantovani A, Shanebeck K, Grabstein KH, Dower SK: Interleukin-1 signalling occurs exclusively via the type-1 receptors. Proc Natl Acad Sci USA 90:6155, 1993.
15. 15. Golotta F, Re F, Muzio M, Bertini R, Polentarutti N, Sironi M, Giri JG, Dower SK, Sims JE, Mantovani A: Interleukin 1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. Science 261:472, 1993.
16. 26. Re F, Muzio M, De Rossi M, Polentarutti N, Sironi M, Giri JG, Dower SK, Sims JE, Mantovani A: The type II "receptor" as a decoy target for interleukin 1 in polymorphonuclear leukocytes: characterisation of induction by dexamethasone and ligand binding properties of the released decoy receptor. J Exp Med 179:739, 1993.
17. 17. Nielsen JH, Jensen D, Pedersen JA, Andersen HU, Stahl M: Expression of type 1 interleukin 1 receptors (IL1-R1) in rat and human pancreatic islets. Eur J Endocrinol 130(suppl 1):30, 1994.
18. 18. Nicoletti F, Marco RD, Barcellini W, Magro G, Schorlemmer HU, Kurrle R, Lunetta M, Grasso S, Zaccone P, Meroni PL: Protection from experimental autoimmune diabetes in the non-obese diabetic mouse with soluble interleukin-1 receptor. Eur J Immunol 24:1843, 1994.
19. 19. Pociot F, Rønningen KS, Bergholdt R, Lorenzen T, Johannesen J, Ye K, Dinarello CA, Nerup J, and the Danish Study Group of Diabetes in Childhood: Genetic susceptibility markers in Danish patients with type 1 diabetes-evidence for polygenecity in man. Autoimmunity 19:169, 1994.
20. 20. Bergholdt R, Karlsen AE, Johannesen J, Hansen PM, Dinarello CA, Nerup J, Pociot F, and the Danish Study Group of Diabetes in Childhood: Characterisation of polymorphisms of an interleukin-1 receptor type 1 gene (IL1R1) promoter region (P2) and their relation to insulin-dependent diabetes mellitus (IDDM). Cytokine (in press).
21. 21. Bingley PJ, Bonifacio E, Shattock M, Gillor HA, Sawtell PA, Dunger DB, Scott RDM, Bottazzo GF, Gale EAM: Can islet cell antibodies predict IDDM in the general population? Diabetes Care 16:45, 1993.
22. 22. Tienari PJ, Tuomilehto-Wolf E, Tuomilehto J, Peltonen L, and the DIME Study Group: HLA haplotypes in type 1 (insulin-dependent) diabetes mellitus: molecular analysis of the HLA-DQ locus. Diabetologia 35:254, 1992.
23. 23. Tuomilehto-Wolf E, Tuomilehto J, Cepaitis Z, Lounamaa R, and the DiMe Study Group: New susceptibility haplotype for type 1 diabetes. Lancet ii:299, 1989.
24. 24. Tuomilehto-Wolf E, Tuomilehto J, Hitman GA, and the DiMe Study Group: DQA1 and DQB1 heterodimers in insulin-dependent diabetes mellitus. A genetic-epidemiology study in Finland. Ann Med 24:533, 1992.
25. 25. Tuomilehto J, Lounamaa R, Tuomilehto-Wolf E, Reunanen A, Virtala E, Kaprio EA, Åkerblom HK, and the Childhood Diabetes in Finland (DiMe) Study Group: Epidemiology of childhood diabetes mellitus in Finland-background of a nationwide study of type 1 (insulin-dependent) diabetes mellitus. Diabetologia 35:70, 1992.
26. 26. Diabetes Epidemiology Research International Group: Geographic patterns of childhood insulin-dependent diabetes mellitus. Diabetes 37:1113, 1988.
27. 27. Kambo PK, Hitman GA, Mohan V, Ramachandran A, Snehalatha C, Suresh S, Metcalfe KA, Ryait BK, Viswanathan M: The genetic predisposition to fibrocalculous pancreatic diabetes. Diabetologia 32:45, 1989.
28. 28. Balnaves ME, Nasioulas S, Dahl H-HM, Forrest S: Direct PCR from CVS and blood lysates for detection of cystic fibrosis and Duchenne muscular dystrophy deletions. Nucleic Acids Res 19:115, 1991.
29. 29. Nomura N, Ota M, Tsuji K, Inoko H: HLA-DQB1 geno-typing by a modified PCR-RFLP method combined with group-specific primers. Tissue Antigens 38:53, 1991.
30. 30. Breslow NE, Day NE: The Analysis of Case-Control Studies. Lyon, France, No. 32, 1989.
31. 31. Siddiqi A, Metcalfe KA, Lai M, Bingley PJ, Sachs J, Bottazzo GF, Gale EAM, Hitman GA: Susceptibility loci in ICA positive subjects, IDDM and other autoimmune disease: implications for disease prediction. Diabetologia 37(suppl 1):A55, 1994.
32. 32. Green A, Gale EAM, Patterson C, for the EURODIAB-ACE Study Group: Incidence of childhood-onset insulin dependent diabetes mellitus: the EURODIAB-ACE Study. Lancet 339:905, 1992.
33. 33. Tuomilehto-Wolf E, Tuomilehto J: DR3, DR4 heterozygosity is not the reason for the high incidence of IDDM in Finland. Diabetes 39(suppl 21A):81, 1990.
34. 34. Fennessy M, Metcalfe KA, Hitman GA, Niven M, Biro PA, Tuomilehto J, Tuomilehto-Wolf E, Childhood Diabetes in Finland (DiMe) Study Group: A gene in the HLA class 1 region contributes to insulin dependent diabetes in the Finnish population. Diabetologia 37:937, 1994.
35. 35. Pocoit F, Molvig J, Wogensen L, Worsaae H, Nerup J: A Taq I polymorphism in the human interleukin-1β (IL-1β) gene correlates with IL-1β secretion in vitro. Eur J Clin Invest 22:396, 1992.
36. 36. Metcalfe KA, Hitman GA, Fennessy MJ, McCarthy MI, Tuomilehto J, Tuomilehto-Wolf E, DiMe (Childhood Diabetes in Finland) Study Group: In Finland insulin gene region encoded susceptibility to IDDM exerts maximum effect when there is low HLA-DR associated risk. Diabetologia (in press).
37. 37. Serjeantson SW, Ranford PR, Kirk RI, Kohenen-Copish MRJ, Mohan V, Ramachandran A, Snehalatha C, Viswanathan M: HLA-DR and -DQ genotyping in insulin-dependent diabetes patients in South India. Disease Markers 5:101, 1987.
38. 38. Hitman GA, Karir PK, Sachs JA, Ramachandran A, Snehalatha C, Viswanathan M, Mohan V: HLA-D region RFLPs indicate that susceptibility to insulin-dependent diabetes in South India is located in the HLA-DQ region. Diabetic Med 5:57, 1988.
39. 39. Awata T, Shibaski Y, Hirai H, Okabe T, Kanazawa Y, Takaku F: Restriction fragment length polymorphism of the insulin gene in Japanese diabetic and non-diabetic subjects. Diabetologia 28:911, 1985.
40. 40. Undlien DE, Hamaguchi K, Kimura A, Tuomilehto-Wolf E, Swai ABM, McLarty DG, Tuimilehto J, Thorsby E, Rønningen KS: IDDM susceptibility associated with polymorphisms in the insulin gene region. A study of blacks, Caucasians and Orientals. Diabetologia 37:745, 1994.
41. 41. Cornall RJ, Prins J-B, Todd JA, Pressey A, DeLarato NH, Wicker LS, Peterson LB: Type 1 diabetes in mice is linked to the interleukin-1 receptor and Lsh/Ity/Bcg genes on chromosome 1. Nature 353:262, 1991.
42. 42. Mandrup-Poulsen T, Pocoit F, Molvig J, Shapiro L, Nilsson P, Emdal T, Roder M, Kjems L, Dinarello CA, Nerup J: Monokine antagonism is reduced in patients with IDDM. Diabetes 43:1242, 1994.